NCT04524572 (WALK) is a NA clinical trial of Motion sensor in Cardiovascular Risk Factor, sponsored by Ottawa Heart Institute Research Corporation.

Who is sponsoring NCT04524572?

NCT04524572 is sponsored by Ottawa Heart Institute Research Corporation.

What drugs are being tested in NCT04524572?

Interventions in NCT04524572: Motion sensor.

What condition does NCT04524572 study?

NCT04524572 studies Cardiovascular Risk Factor, Cardiovascular Diseases.

Is NCT04524572 still recruiting?

NCT04524572 is currently completed. Last updated 6 September 2023.

Last reviewed 2023-09-06 · How we verify

NCT04524572: WALK

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Role of a Motion Sensor With Accompanying Web Application on Step Counts, Energy Balance, and Metabolic Markers in Nurses

Completed NA Last updated 6 September 2023

What this trial tests

NA trial testing Motion sensor in Cardiovascular Risk Factor in 76 participants. Completed in 1 August 2015.

Timeline

26 November 2013

Primary endpoint
25 April 2014

1 August 2015

Quick facts

Lead sponsor	Ottawa Heart Institute Research Corporation
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	supportive care
Enrollment	76
Start date	26 November 2013
Primary completion	25 April 2014
Estimated completion	1 August 2015
Sites	1 location across Canada

Drugs / interventions tested

Motion sensor

Conditions studied

Cardiovascular Risk Factor — all drugs for Cardiovascular Risk Factor →
Cardiovascular Diseases — all drugs for Cardiovascular Diseases →

Sponsor

Ottawa Heart Institute Research Corporation

Who can join

Adults 18 to 90, any sex, with Cardiovascular Risk Factor or Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this prospective randomized controlled trial is to explore the role of a motion sensor with accompany web application on step counts, energy balance, and metabolic markers in nurses. Additionally, eating behaviours, behavioural regulation in exercise, and mood states that may impact these parameters will also be examined.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Motivation Predicts Change in Nurses' Physical Activity Levels During a Web-Based Worksite Intervention: Results From a Randomized Trial.
Brunet J, Tulloch HE, Wolfe Phillips E, Reid RD, et al · · 2020 · cited 8× · PMID 32915158 · DOI 10.2196/11543
Work-related factors predict changes in physical activity among nurses participating in a web-based worksite intervention: A randomized controlled trial.
Brunet J, Black M, Tulloch HE, Pipe AL, et al · · 2021 · cited 7× · PMID 34749710 · DOI 10.1186/s12912-021-00739-4

Verify or expand the search:

Other recruiting trials for Cardiovascular Risk Factor

Currently open trials in the same condition.

NCT07268781 — Impact of Golden Rice-Piper Crocatum Cookies on Lipid Control in Diabetes Mellitus Patients · NA · active not recruiting
NCT06225544 — Lumasiran in Hyperoxalaemic Patients on Haemodialysis · Phase 2 · recruiting
NCT06372054 — TORNADO-Omics Techniques and Neural Networks for the Development of Predictive Risk Models · recruiting
NCT05887622 — The Potassium Supplementation Study · NA · recruiting
NCT04962061 — A Combined Multidomain Intervention to Prevent Cognitive Decline Associated With Cardiovascular Risk Factors. · NA · recruiting

Other Ottawa Heart Institute Research Corporation trials

Trials by the same sponsor.

NCT06907251 — Dapagliflozin for Long COVID Syndrome · Phase 3 · not yet recruiting
NCT07002450 — Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus in The Emergency Departm · NA · recruiting
NCT06832085 — Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation · Phase 4 · recruiting
NCT06556667 — MAX - SHOCK Clinical Trial · NA · recruiting
NCT06816888 — Impact of Automatic Prompts in Echocardiographic Reports on Referral to Cardiology · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04524572 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ottawa Heart Institute Research Corporation
Last refreshed: 6 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04524572.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing